A survival analysis using the Kaplan–Meier estimator showed the potential impact of GAGE2A and CT45A1 up-regulation on poor disease-free survival prognosis in ovarian tumors, which was confirmed by a multivariate survival analysis. The gene discussed is GAGE2A; the disease is ovarian neoplasm.